Iodine-Copper Complex Disinfectant for Low-Toxicity Antimicrobial Action
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current iodine-based antimicrobial solutions face challenges in achieving a balance between effectiveness against pathogens and toxicity to healthy tissues, particularly in wound healing, with existing formulations often causing cytotoxicity and delaying healing processes.
Innovation Solution
A stable antimicrobial composition comprising potassium iodide and copper sulfate in a carrier liquid, without additional buffers or surfactants, which generates a controlled release of free iodine (100-330 ppm) and copper complexes, maintaining a biologically acceptable pH (3.5-7.5) for prolonged use without toxicity or irritation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If high levels of iodine are used in antiseptic preparations, then antimicrobial effectiveness is improved, but cytotoxicity and tissue irritation increase
Solution Approach 1:
The patent changes the chemical form of iodine from elemental iodine (I2) to iodide ions (I-) combined with copper ions (Cu2+), maintaining antimicrobial effectiveness while reducing cytotoxicity. This parameter change in chemical state allows the composition to achieve both high reliability against pathogens and reduced harmful effects on tissue.
Solution Approach 2:
The patent creates a composite antimicrobial system combining iodide and copper sulfate, where the synergistic interaction between these components produces enhanced antimicrobial activity at lower concentrations than elemental iodine alone, thereby reducing cytotoxicity while maintaining effectiveness.
2Reliability
If conventional iodine formulations are used on open wounds, then antimicrobial protection is provided, but wound healing is delayed
Solution Approach 1:
The patent modifies the chemical parameters of iodine delivery by using iodide-copper complexes instead of elemental iodine, which changes the mechanism of action to be less disruptive to cellular processes involved in wound healing, thereby maintaining protection while accelerating healing.
Solution Approach 2:
The copper sulfate acts as an intermediary that enables iodide to deliver antimicrobial protection through a different mechanism that does not interfere with wound healing processes, mediating between the need for antimicrobial activity and the need for tissue regeneration.
3Object-affected harmful factors
If Povidone-iodine is diluted to reduce toxicity, then cytotoxicity is reduced, but antimicrobial efficacy decreases
Solution Approach 1:
The patent uses a composite of iodide and copper sulfate that creates synergistic antimicrobial activity, allowing the formulation to maintain high efficacy at low concentrations without requiring dilution, thus avoiding the trade-off between toxicity reduction and efficacy maintenance.
Solution Approach 2:
The patent changes the concentration parameter of active iodine species by using iodide-copper complexes that are effective at much lower concentrations (100-330 ppm free iodine equivalent) compared to conventional Povidone-iodine formulations, thereby maintaining efficacy while reducing cytotoxicity.
4Speed
If elemental iodine is applied to skin, then immediate antimicrobial action is achieved, but pain and irritation occur
Solution Approach 1:
The patent changes the chemical form from elemental iodine to iodide-copper complexes, which achieve rapid antimicrobial action through a different mechanism that does not cause the pain and irritation associated with elemental iodine application.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition exhibits sustained antimicrobial activity for 24 hours or more with a greater than 4 log kill against pathogens, including ESKAPE pathogens, and total eradication of coronaviruses within 30 minutes, while remaining stable for at least 12 months without precipitation or loss of efficacy, making it safe and non-irritating for extended contact with skin and tissues.
Implementation Method 1
A stable antimicrobial composition comprising potassium iodide and copper sulfate in a carrier liquid, without additional buffers or surfactants, which generates a controlled release of free iodine (100-330 ppm) and copper complexes
Data Source
AI summary
Liquid antimicrobial disinfectant compositions for treatment of coronaviruses and specifically the Covid-19 virus (SARS-CoV-2) on skin and surfaces such as PPE (personal protective equipment) are disclosed that are highly efficacious and exhibit total eradication below detectable limits at 30 minutes (>6 log kill) against coronavirus (resulting in complete inactivation), while remaining non-toxic, safe and non-irritating (including at a cellular level and with extended contact) to skin and endogenous tissue. Such disinfectant compositions are additionally highly effective against other pathogens, have extended antimicrobial and antiviral activity for more than 24 hours, have a bio-compatible pH, are suitable for personal, clinical and surgical use and are safe to skin, mucous membranes and wounds, remain stable without precipitation, discoloration or loss of antimicrobial efficacy for at least 12 months, and are beneficial for a range of applications and uses in improving and supporting human and animal health.